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In Brief
Companion dogs from the obesity-prone
Labrador retriever breed were found to
carry a mutation in POMC in this study by
Raffan et al. The mutation is predicted to
disrupt production of the neuroactive
peptides b-MSH and b-endorphin and
was associated with greater weight,
adiposity, and foodmotivation in affected
dogs.
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Sequencing of candidate genes for obesity in Lab-
rador retriever dogs identified a 14 bp deletion in
pro-opiomelanocortin (POMC) with an allele fre-
quency of 12%. The deletion disrupts the b-MSH
and b-endorphin coding sequences and is associ-
ated with body weight (per allele effect of 0.33 SD),
adiposity, and greater food motivation. Among other
dog breeds, the deletion was only found in the
closely related flat-coat retriever (FCR), where it is
similarly associated with body weight and food
motivation. The mutation is significantly more com-
mon in Labrador retrievers selected to become
assistance dogs than pets. In conclusion, the dele-
tion in POMC is a significant modifier of weight and
appetite in Labrador retrievers and FCRs and may
influence other behavioral traits.
INTRODUCTION
In developed countries, the prevalence of canine obesity ranges
between 34% and 59% (Colliard et al., 2006; Courcier et al.,
2010; Edney and Smith, 1986; Lund et al., 2006; McGreevy
et al., 2005). Obesity in dogs is associated with reduced lifespanCell Metabolism 23, 893–900
This is an open access article undand several specific morbidities similar to those seen in human
obesity (German, 2006; Lawler et al., 2008; Raffan, 2013; Zoran,
2010). Recent changes in the prevalence of obesity in dogs
mirror increases in the prevalence of the human condition, and
similar environmental factors such as reduced exercise and
ready access to high-calorie food are implicated. However,
despite the fact that dog owners control their pets’ diet and ex-
ercise, susceptibility to obesity varies between dog breeds,
which suggests the influence of genetic factors.
Over the past 20 years, insights from human and mouse ge-
netics have illuminated multiple pathways within the brain that
play a key role in the control of food intake (Yeo and Heisler,
2012). In particular, we now know that the hypothalamic leptin
melanocortin signaling pathway is crucial for the appropriate
control of food intake, with genetic disruption of most compo-
nents of the pathway resulting in severe obesity in both mouse
and man (Yeo and Heisler, 2012). However, the majority of com-
mon obesity in humans is polygenic, with the most reproducible
finding from genome-wide association studies, an association at
the fat mass and obesity (FTO) locus, explaining only a small
component of obesity risk (Tung et al., 2014).
Of all dog breeds for which data have been reported, Labra-
dor retrievers have the greatest documented obesity preva-
lence (Edney and Smith, 1986; Lund et al., 2006; Mason,
1970; O Neill et al., 2014) and have been shown to be more
food motivated than other breeds (Raffan et al., 2015). The
fact that most modern dog breeds originated relatively recently
from a small number of founder animals makes the genetic, May 10, 2016 ª 2016 The Authors. Published by Elsevier Inc. 893
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basis of canine traits particularly amenable to dissection (Sutter
and Ostrander, 2004).
In order to begin exploiting the power of canine genetics to
identify alleles predisposing to obesity, we studied a cohort
of companion and assistance Labrador retriever dogs. Here,
we report that a 14 bp deletion in the pro-opiomelanocortin
(POMC) gene, which results in the disruption of b-MSH (melano-
cyte-stimulating hormone) and b-endorphin, is associated with
increased body weight, adiposity, and food motivation in both
Labrador retrievers and the closely related flat-coat retrievers
(FCRs). We also find that the mutation is significantly more com-
mon in Labradors selected to become assistance dog breeding
stock than those selected to be companions.
RESULTS
Identification of a POMC Deletion in Obese Labrador
Retrievers
We recruited a cohort of 310 pet and assistance dog Labrador
retrievers. Dogs were weighed, and their body condition score
(a validated measure of adiposity that accounts for variation in
body morphology within and across breeds; Laflamme, 1997;
Mawby et al., 2004) was assessed by independent veterinary
professionals.
Initially, the coding sequence of three candidate obesity
genes, melanocortin-4 receptor (MC4R), agouti-related peptide
(AGRP), and POMC, all part of the hypothalamic melanocortin
pathway, was examined in 15 obese and 18 lean Labrador
retrievers. No variants from the reference sequence were
identified in AGRP. In MC4R, four novel variants were identi-
fied, but there was no significant difference in distribution of
the variants between lean and obese groups (Table S1, avail-
able online).
In POMC, 11 novel variants were identified (Table S1), but only
one was distributed differently between lean and obese groups:
a 14 bp deletion at position 17:19431807-19431821 was found
in 10/15 obese dogs (two homozygous and eight heterozygous)
and 2/18 lean dogs (both heterozygous). The deletion spanned
what is annotated in the canine reference sequence (Can-
Fam3.1) as a 2 bp intron between exons 3 and 4. However, all
Labrador retrievers and 35 dogs of 24 other breeds in which
the region was re-sequenced (Table S2) were found to have
the same single base pair insertion at 17:19431820 (T/TC), which
has the effect of adding a base to the ‘‘intron’’ and encoding an
extra amino acid (POMC p.P187 > PE). Sequence alignment
shows this increases similarity to the human reference sequence
(Figures 1 and S1). A TaqMan assay was developed for subse-
quent genotyping of the mutation.Figure 1. A 14 bp Deletion in Canine POMC at Position 17: 19431807
Predicted to Stop Production of the Neuroactive Peptide Derivatives b
(A) Chromatogram showing capillary sequencing results from wild-type, homozy
(B) Schematic diagram of POMC showing the pro-peptide and cleavage products
position of the red line and results in loss of sequence homology from amino acid 1
The red box indicates the downstream products that are not produced as a con
(C) Alignment of human and canine wild-type POMC and the peptide sequence re
human and wild-type dog sequences, particularly for cleavage sites (bold type) a
ACTH (human 138–176), and a-MSH (human 138–150). Red, peptide product
237–267).Association of POMC Deletion with Weight, Adiposity,
and Food Motivation in Labrador Retrievers
The association of the deletion with body weight and adiposity
was tested in the wider cohort of 310 Labrador retrievers. The
POMC deletion was positively associated with higher body
weight (p < 0.0001; mean effect size 1.90 kg per deletion allele,
equivalent to 0.33 SDs) and body condition score (p < 0.0001;
mean effect size 0.48 scale point increase per deletion allele)
(Figure 2). Further, food motivation, tested using the previously
validated Dog Obesity Risk Assessment (DORA) questionnaire
(Raffan et al., 2015), was positively associated with the presence
of the mutation (p = 0.001; mean effect size 9.9% per deletion
allele) (Figure 2).
The POMC Deletion Is Found in FCRs, Where It Is Also
Associated with Weight and Food Motivation
The mutation was absent from dogs of 38 other diverse breeds
(Table S2) but present in FCRs. In a sample of 96 unrelated
FCRs, the allelic frequency of the POMC deletion was 60%, with
genotypes distributed approximately evenly (32% wild-type,
29% heterozygous, and 39% homozygous deletion), indicating
significant divergence from Hardy-Weinberg equilibrium (p =
0.01). FCRs are closely related to Labrador retrievers (Vonholdt
et al., 2010); both breeds originated in the 19th century from a
now extinct breed, the St. John’s water dog. In both breeds, the
mutation was associated with identical alleles at flanking micro-
satellite markers 600 kb apart, indicating identity by descent
and a common ancestral origin of the mutation (Table S3).
We recruited 200 further FCRs for genotyping and phenotypic
assessment. The POMC mutant allele was associated with
higher body weight (p < 0.0001; mean effect size 1.86 kg per
deletion allele, equivalent to 0.33 SDs) and food motivation
(p < 0.0001; mean effect size 7.4% per deletion allele) (Figure 3).
Canine b-MSH Is Produced and Activates Melanocortin
Receptors
POMC is translated as a pro-protein, and a series of bioactive
peptides are produced by proteolytic cleavage. The deletion
(POMC p.E188fs) is predicted to disrupt the coding sequence
of POMC and cause loss of production of b-MSH and b-endor-
phin. b-MSH is a known product of the human POMC gene,
but in the rodent genome, the N-terminal proteolytic processing
site that precedes b-MSH is absent. Canine POMC has greater
similarity to the human peptide sequence (79%) than does the
mouse (69%). All proteolytic cleavage sites critical to processing
human POMC, including those flanking b-MSH, are conserved in
the dog, and the peptide sequence of the produced cleavage
products is either identical or very similar (Figure 1C).-19431820 Causes a Frameshift Mutation in the Coding Sequence,
-MSH and b-Endorphin
gous deletion, and heterozygous dogs.
. Arrows show di-basic cleavage sites. The mutant peptide is indicated by the
87 of the wild-type dog POMC and a pro-peptide that is 52 amino acids longer.
sequence of the mutation.
sulting from the frameshift mutation. Sequence similarity is high (79%) between
nd neuroactive peptides (highlighted in color). Blue: g-MSH (human 138–150),
s disrupted by mutation: b-MSH (human 217–234) and b-endorphin (human
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Figure 2. Effect of POMC Deletion Geno-
type onMeasures of Obesity and FoodMoti-
vation in Labrador Retrievers
Predicted mean (95% confidence interval) (A)
weight (n = 258), (B) body condition score (n = 236),
and (C) food motivation score (n = 210) by geno-
type after linear regression adjustment for age,
sex, neuter status, and color are shown. Mean
effect size (b), 95% confidence interval, and p
values are shown.The MSH peptides exert their actions on body weight through
two closely related G protein-coupled melanocortin receptors.
To test whether canine b-MSH and a-MSH have comparable re-
ceptor-activating effects on their cognate receptors, we cloned
the canine MC3R and MC4R and expressed them in Cos-7
cells, before treating with a-MSH or b-MSH (both canine and
human) and testing the downstream response by measuring
cAMP (cyclic AMP) concentrations. The activity profiles of
canine a- and b-MSH on the canine MC3R and MC4R were
indistinguishable from those of the human ligands on the human
receptors (Figure 4).
Frequency of POMC Deletion Is Higher in Assistance
Dog Populations
In studies designed tomore robustly determine the prevalence of
this deletion among Labrador retrievers, we accessed DNA from
further cohorts of dogs. Of 383 Labrador retrievers from the
UK, 78% of dogs were wild-type, 20% heterozygous, and 2%
homozygous deletion (allele frequency 12%, proportions in
Hardy-Weinberg equilibrium, statistically similar to the popula-
tion used to test association with obesity and food motivation);
allele frequencies were the same in 28 Labrador retrievers from
the United States. Notably, in a group of 81 Labrador retrievers
used as assistance dog breeding stock, the allelic frequency
was markedly higher at 45%. It is also of note that the allelic896 Cell Metabolism 23, 893–900, May 10, 2016distribution in the assistance dogs was
markedly out of Hardy-Weinberg equilib-
rium (23% wild-type, 64% heterozygous,
and 12%homozygous deletion; p < 0.01),
suggesting the possibility of positive se-
lection toward heterozygous dogs in that
population.
DISCUSSION
We have shown that a frameshift deletion
mutation in POMC is strongly associated
with weight, adiposity, and appetite in
Labrador retriever and FCR dogs. In both
breeds, each deletion allele confers an in-
crease of 0.33 SDs in weight. This effect
size (over three times the per-allele effect
observed at the FTO locus in humans;
Locke et al., 2015) is particularly notable
given the extent to which owners, rather
than the dogs themselves, control the
amountof foodandexercisedogs receive.While a previous study reported two non-coding SNPs in tumor
necrosis factor (TNF)were associatedwith increased body condi-
tion score in Labradors, the cohort size was small, and it did not
address thecrucial phenotypesofweightor foodmotivation (Man-
kowska et al., 2016). It has been reported that owners of more
highly food-motivated dogs make greater efforts to limit their
dogs’ access to food (Raffan et al., 2015). However, there is evi-
dence to suggest dogs are able to influence both the type and
quantity of food offered to them by their owners (Day et al.,
2009). It is possible that behavior changes related to the mutation
are sufficient to lead to increased food intake (eitherbyscavenging
or soliciting owner-provided food). Furthermore, it is well recog-
nized that in mice, failure of signaling at the MC4R enhances
caloric efficiency (Ste Marie et al., 2000), a phenotype we cannot
exclude here.
The association of the POMC deletion described with body
weight, adiposity, and food motivation in both Labrador re-
trievers and FCRs is strong and of a similar magnitude in both
breeds. It is possible that the high prevalence of the mutation
in Labrador retrievers contributes to their well-known predispo-
sition to obesity compared to other breeds of dog. We acknowl-
edge that there is a higher prevalence of this deletion in FCRs, a
breed not previously noted to be especially obesity prone, but
note that obesity has not been studied systematically before in
this relatively uncommon breed of dog.
Figure 3. Effect of POMC Deletion Geno-
type onWeight and FoodMotivation in FCRs
Predicted mean (95% confidence interval) (A)
weight (n = 196) and (B) food motivation score (n =
219) by genotype after linear regression adjust-
ment for age, sex, neuter status, and color are
shown. Mean effect size b, 95% confidence in-
terval and p values are shown.The particularly high allelic frequency of the POMC deletion in
assistance dogs is intriguing. Temperament and ‘‘trainability’’
are the main drivers for selection of assistance dogs, and
‘‘positive reinforcement’’ with food reward is a mainstay of
puppy training. We therefore hypothesize that dogs carrying
the POMC deletion may be more likely to be selected as assis-
tance dogs. The fact that the allelic frequency at this locus is
significantly out of Hardy-Weinberg equilibrium in assistance
dog breeding stock could be seen as support for the notion
that selection has occurred at this locus.
The mechanism by which reduced b-MSH and b-endorphin
due to the mutation causes behavioral and weight phenotypes
remains to be precisely elucidated. Previously, study of the
role of b-MSH in regulation of appetite and energy homeosta-
sis has been limited by the fact that rodents lack the proximal
di-basic cleavage site necessary for the proteolytic cleavage
event that produces b-MSH, and the scarcity of human
patients lacking functional b-MSH (Challis et al., 2002; Lee
et al., 2006). However, studies of humans with POMC muta-
tions resulting in aberrant forms of b-MSH (due to disruption
of the receptor binding site; Lee et al., 2006; or production
of an aberrant b-MSH/b-endorphin fusion protein; Challis
et al., 2002) have suggested that b-MSH is important in con-
trolling appetite and obesity development in man, with hyper-
phagia notable in patients with both mutations. Our current
observation that the relationship between weight, body condi-
tion score, and appetite and genotype is proportional to the
number of mutant alleles present is consistent with the fact
that these human b-MSH mutations were found in heterozy-
gous form (Challis et al., 2002; Lee et al., 2006). This is likely
due, as in humans, to straightforward haploinsufficiency, but
alternative explanations (e.g., altered splicing leading to
production of an aberrant peptide acting as an antagonist at
the MC4R) exist. Ideally, the sequence and relative expression
of POMC RNA transcripts would be examined, but the diffi-
culty of obtaining suitable samples from a companion dog
cohort precludes this at present.
The role of b-endorphin in regulating appetite, satiety, and
energy balance is less well understood, but it has been proposed
to underlie oro-sensory reward in high-need states or when
the stimulus is especially valuable (Mendez et al., 2015). How-Cell Mever,mice selectively lackingb-endorphin
are hyperphagic and obese, suggesting
that the loss of both neuropeptides could
contribute, in combination, to the pheno-
type seen in dogs carrying this frameshift
POMCmutation (Appleyard et al., 2003).
In conclusion, further study of dogs
naturally lacking these important bio-active peptides encoded by thePOMC gene should provide novel
information regardingmelanocortin and opioid biology and opens
up potential novel therapeutic approaches to at least some forms
of canine obesity.
EXPERIMENTAL PROCEDURES
Ethical Approval
The research was approved by the Ethical Review Committee of the Depart-
ment of Veterinary Medicine, University of Cambridge (CR73 and CR125),
with sample collection at other centers also approved by local ethical review
committees: Animal Health Trust Research Ethics Committee, MIT Animal
Care Protocol Lindblad-Toh 0913-073-16, Veterinary Ethical Review Com-
mittee of the University of Edinburgh (VERC 11/12), University of Liverpool
Research Ethics Committee RETH000353, Swedish Animal Ethical Committee
(C138/12, C62/10, and C2/12), and the Swedish Animal Welfare Agency
(no. 31-1711/10). All dog owners gave full written consent to participate in
the research.
Dogs to Test Genotype/Obesity Association
Labrador retriever samples were collected from dogs from a large assistance
dog breeding colony (n = 81) or that were pet dogs from the UK (n = 310).
Pet dogs were recruited either after their owners volunteered in response to
an email from the UK Kennel Club sent to over 15,000 Labrador retriever
owners, or via participating veterinary practices. Inclusion and exclusion
criteria were set in advance of dog recruitment. Inclusion criteria were that
dogs must be greater than 1 year of age and have submitted DNA and at least
one of the following: weight, body condition score, or DORA questionnaire
response, along with data regarding age, gender, and color. Exclusion criteria
were current treatment with drugs that could affect appetite or weight (e.g.,
corticosteroids or anti-seizure medication) or being under veterinary care for
diagnosis or treatment of ill health (12 dogs excluded).
Labrador retrievers included in the analysis had mean (SD) age of 6.1 years
(2.6), weight of 32 kg (5.7), body condition score of 5.6 units (1.2), and food
motivation score of 63% (25). Half were male and half female; 56% of both
sexes were neutered. Fifty-six percent of dogs were black, 34% yellow, and
10% chocolate.
FCRs were recruited via a Kennel Club email request for volunteers sent
to over 7,000 owners of FCRs. DORA questionnaire responses, body
weight, and DNA samples were collected from all participant dogs, but
body condition scores were not available. Inclusion criteria were availability
of DNA, DORA questionnaire response, and weight, along with data
regarding age, gender, and color. FCRs were excluded from the analysis
if they were less than 1 year old or owners reported specific ill health. Health
information was gathered by review of veterinary clinical records by a veter-
inary surgeon (ER).etabolism 23, 893–900, May 10, 2016 897
Figure 4. Activity of Canine b-MSH on MC4R and MC3R
Canine b-MSHacts on the caninemelanocortin receptors in a similar fashion to
the analogous human receptor/ligand pairs. Equivalent results were obtained
when human and dog MC4R and MC3R were stimulated with a-MSH (Error
bars represent SEM).FCRs included in the analysis hadmean (SD) age of 5.3 years (2.0), weight of
32 kg (5.6), and foodmotivation score of 67% (22). Fifty-two percent weremale
(55% neutered) and 48% female (68% neutered). Eighty-five percent of FCRs
were black and 15% liver in color.
Assessment of Weight, Adiposity, and Food Motivation
All dogs were weighed on electronic scales. Body condition scores were as-
sessed by qualified veterinary professionals who used a previously validated
standard chart (Laflamme, 1997; Mawby et al., 2004). Foodmotivation was as-
sessed by use of the previously validated DORA questionnaire, which is an
owner-reported measure of dogs’ behavior related to food, as tested using a
panel of questions (Raffan et al., 2015).
Dogs Used to Test Population Distributions
The population distribution of the POMCmutation was tested in each affected
breed in cohorts of dogs collected without reference to obesity or weight;
383 British Labrador retrievers, 28 American Labrador retrievers, and 96
FCRs were screened. Other breed samples were from unrelated dogs from
the United States or Sweden.
Genomic DNA Sequencing
DNA was extracted from saliva samples collected using Performagene
(PG-100) kits (DNA Genotek). PCR primers were designed to amplify coding
regions and flanking intronic regions of candidate genes. Initial sequencing
was performed in 18 lean Labrador retrievers, selected because their owners
reported the dogs were not very food motivated, and 15 obese Labrador re-
trievers. Sequences were aligned using Sequencher software (Gene Codes)
against the canine reference sequence (CanFam3.1).
Genotyping the POMC Deletion
A TaqMan genotyping assay was developed to allow rapid genotyping of the
mutation. A single pair of primers flanking the deletion site and paired probes
that detected either the wild-type or mutant allele sequence were combined in
a duplex reaction. After optimization of reaction efficiency and detection
thresholds, Ct (cycle threshold) values within 0.5 cycles were expected for
heterozygous samples. Where Ct > 10 for both alleles but delta Ct was >0.5,
the same primer pair was used to amplify the fragment by standard PCR
with subsequent size separation using electrophoresis on a 3% TBE/agarose
gel and visualization of wild-type, deletion, or both alleles against reference
controls. Primer sequences are available upon request. Investigators perform-
ing genotyping were blinded to the phenotype of the dogs.
MC4R and MC3R Cloning
The coding sequence of the single exons ofMC4R and MC3R were amplified
from dog (Labrador retriever) genomic DNA using Pfu Ultra Fusion HS DNA898 Cell Metabolism 23, 893–900, May 10, 2016Polymerase (Agilent Technologies) according to the manufacturer’s instruc-
tions. Restriction sites for EcoR1 and Xba1 were introduced into the amplicon
by incorporation in the PCR primers to allow subsequent sub-cloning into the
pFLAG-CMV-2 vector (Sigma-Aldrich) with restriction enzymes EcoR1 and
Xba1. Products of ligation were transformed into XL 2 competent E. coli using
thermoporation, and following selection and sequencing to confirm successful
and accurate introduction of the correct sequence, plasmid was extracted
from cultivated clones using the HiSpeed Plasmid Maxi Kit (QIAGEN). Human
MC3R and MC4R clones used herein are as previously described (Yeo et al.,
2003).
Activation by b-MSH and a-MSH of Melanocortin Receptors
COS-7 cells were transfected with dMC3R, dMC4R, hMC4R, or an empty
vector and serum starved for 2 hr before stimulation with either a- or b-MSH
in presence of IBMX. Ligands for use in receptor stimulation experiments
were commercially available for a-MSH (peptide sequence identical in dogs
and humans; Bachem) and human b-MSH (Bachem). Canine b-MSH was
custom synthesized (Cambridge Research Biochemicals). The HitHunter
cAMP XS+ Assay (DiscoverRx), a gain-of-signal competitive immunoassay
based on enzyme fragment complementation technology, was used accord-
ing to the manufacturer’s recommendations to measure the downstream
effect of receptor activation and cAMP generation.
Microsatellite Genotyping
Microsatellite markers 500 kb up- and downstream of the POMC mutation
were identified from the University of California, Davis DOGSET database
(Wong and Neff, 2009), and the suggested primer sequences were used
to amplify and genotype three markers, 17_021E_CT, 17_022B_CA, and
17_022C_CA (DOGSET reference names). A two-stage amplification process
was used: for the first stage, locus-specific forward primers appended with an
M13 sequence tag at the 50 end were used with standard reverse primers, and
in the second stage, a FAM-labeled M13 primer was used with the same
reverse primers to label PCR products before size separation against
GeneScan 500 LIZ dye Size Standard (ThermoFisher Scientific) in the ABI
3700 Genetic Analyzer (Applied Biosystems) and analysis using GeneMapper
software (ThermoFisher Scientific).
Clustal Alignment/Ensembl BLASTP for Sequence Similarity
We used the CLUSTAL Omega 2.1 multiple sequence alignment tool (Sievers
et al., 2011) to align human and dog peptide and nucleotide sequences.
Peptide sequence similarity was calculated using the NCBI BLASTP tool.
Accession Codes
Accession codes for nucleotide sequences used are as follows: dog AGRP,
MC4R, and POMC, and human POMC, Ensembl: ENSCAFG00000020359,
ENSCAFG00000000090, ENSCAFG00000004149, and ENSG00000115138,
respectively. Accession code for dog MC3R is NCBI RefSeq: NC_006606.3.
Peptide sequences for protein alignment for Pomc (mouse), POMC (dog),
and POMC (human) were obtained from UniProt under accession codes
UniProt: P01193, E2RQ39, and P01189, respectively.
Statistical Analysis
Descriptive statistics were generated to assess variance and normality of
distribution prior to analysis. Fisher’s exact test was used to test whether
distribution was different between lean and obese groups for variants identi-
fied in candidate gene sequencing, and the chi-square test was used to test
whether alleles were in Hardy-Weinberg equilibrium within populations. We
investigated association of the deletion with body weight, adiposity, and
food motivation score by linear regression models adjusted for age, sex,
neuter status, and color (to account for their previously reported influence
on body weight; Colliard et al., 2006; Pugh et al., 2015; Robertson, 2003; Sal-
lander et al., 2010). Color was treated as a categorical variable (black, choco-
late/liver, or yellow). Analyses were performed using Stata (StataCorp, 2015).
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